WebinarsLearn how you can apply IDBS Polar to support your everyday analytical needs

Learn how you can apply IDBS Polar to support your everyday analytical needs

Now on-demand

Discover more with Polar webinar series
Session 2

Discover more with Polar

Do you want to learn more about IDBS Polar?

IDBS is committed to supporting you through every step of your digital journey. We take a personal approach to understanding your unique needs and challenges, and want you to get a closer look at some real examples of our platform. Tune into this webinar to get a deeper dive into some common applications of our platform. 

You will see hands-on demos of the following: 

  • Instrument integration 
  • Bioreactor comparison reports 
  • Multivariant analysis 
  • Design of experiment 

 We strive to deliver therapies to patients faster.  

At IDBS, we understand the complexities and challenges faced by BioPharma companies. Our solutions are designed to optimize digital workflows, enhance data integrity and ensure seamless integration across various stages of drug development. 

Watch a teaser below!

Maxresdefault

Key learning points:   

  • Practical applications of how you can utilize IDBS Polar and Polar Insight to assist with your necessary data management by instilling data security confidence. 
  • Real examples of how IDBS Polar and Polar Insight can make a difference in your digital transformation.   
  • How can we fundamentally improve your time to market?  

In summary, IDBS Polar and Polar Insight can significantly enhance your digital transformation efforts by streamlining data management by freeing up your time to focus on your work, removing inefficiencies and improving time to market.

Watch the Webinar

Meet our speakers

The importance of digital transformation - Mike Barnes

Michael Barnes

Lead Solutions Consultant, IDBS

As a Lead Solutions Consultant for IDBS, Michael brings a wealth of knowledge and insights to successfully implement data management solutions for high-profile biopharmaceutical and biotechnology companies. 

Prior to shifting to IDBS, he worked in Pfizer’s BioProcess R&D Cell Line Development group. 

Michael holds an MSc in Biomedical Engineering and Biotechnology from the University of Massachusetts-Lowell.